Physician

Hiren Jagdish Joshi, MD

According to 2025 Medicare claims, Hiren Joshi, MD (NPI: 1316268469) practices nephrology in the Tallahassee, FL market, with the plurality of this provider's patient population coming from Leon, FL. This provider's primary affiliated billing organization is CAPITAL NEPHROLOGY CLINIC, P.A. (NPI: 1801248356; TIN: 812290914) and primary practice location at 32308-4402.

Joshi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 514 traditional Medicare patients, billed 2,115 HCPCS/CPT codes, and received $201,117 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 6,010 prescription claims across 649 beneficiaries totaling $1,636,641 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 42 claims. Open Payments data shows 46 records totaling $735. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $85,105 to $1,636,641. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $7,966 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	522	2,188	$199,750
2016	820	3,615	$259,528
2017	640	2,791	$221,202
2018	639	2,996	$255,097
2019	776	4,661	$392,936
2020	665	3,969	$352,353
2021	580	3,335	$317,318
2022	554	3,009	$280,038
2023	530	2,515	$252,229
2024	514	2,115	$201,117

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	193	787	$85,105
2016	304	1,818	$233,113
2017	316	2,163	$234,742
2018	388	3,797	$360,979
2019	445	5,159	$643,131
2020	472	3,955	$998,109
2021	515	4,372	$970,546
2022	553	5,015	$1,267,730
2023	611	5,475	$1,597,843
2024	649	6,010	$1,636,641

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	66	$9,453
2016	N/R	28	$6,344
2017	N/R	N/R	N/R
2018	N/R	14	$241
2019	N/R	N/R	N/R
2020	N/R	114	$8,013
2021	N/R	70	$5,173
2022	N/R	52	$3,552
2023	N/R	102	$2,488
2024	N/R	42	$901

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	108	115	$135
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	166	189	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	93	156	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	139	186	$70
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	260	963	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	113	3,575	$289,178
Farxiga	Dapagliflozin Propanediol	268	15,938	$285,118
Lupkynis	Voclosporin	24	720	$243,127
Kerendia	Finerenone	116	5,499	$118,026
Januvia	Sitagliptin Phosphate	83	5,977	$109,265

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	14	$398
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	12	$340
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	16	$163

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	46	$735	Fresenius USA Marketing, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Hiren Jagdish Joshi, MD?

Tedicare shows public-source Medicare data for Hiren Jagdish Joshi, MD (NPI 1316268469), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hiren Jagdish Joshi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Hiren Jagdish Joshi, MD?

Hiren Jagdish Joshi, MD is linked to CAPITAL NEPHROLOGY CLINIC, P.A. (billing NPI 1801248356) in the available physician profile data.

Does Hiren Jagdish Joshi, MD have Open Payments data?

Hiren Jagdish Joshi, MD has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.